BEIJING KONRUNS PHARMACEUTICAL

beijing-konruns-pharmaceutical-logo

Konruns Pharmaceutical is a manufacturing company. They produce special drugs for the medical and healthcare industries. Their drugs include CX1026, CX1003, and KC1036.

#SimilarOrganizations #Financial #More

BEIJING KONRUNS PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Manufacturing Medical Pharmaceutical

Founded:
2003-09-03

Status:
Active

Contact:
86-10-8289-8888

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content Nginx PHP PHP 7 China Ministry Of Public Security China Unicom Xinnet DNS


Similar Organizations

beijing-jinhao-pharmaceutical-co-logo

Beijing Jinhao Pharmaceutical Co.

Beijing Kinghawk Pharmaceutical specializes in biotech and pharmaceutical product development.

bliss-gvs-pharma-logo

Bliss Gvs Pharma

Bliss Gvs Pharma is a pharmaceutical company that develops manufactures and market high-quality pharmaceutical products that are affordable.

hainan-poly-pharm-logo

Hainan Poly Pharm

Hainan Poly Pharm manufactures and distributes pharmaceutical products.

not_available_image

Jiangsu Wanbang Biochemical Pharmaceuticals Co. Ltd

Jiangsu Wanbang Biochemical Pharmaceuticals Co. Ltd. develops, manufactures, and distributes pharmaceutical products.

mayinglong-logo

Mayinglong

Mayinglong Pharmaceutical Group manufactures and markets pharmaceutical products.

pharos-indonesia-logo

Pharos Indonesia

Pharos Indonesia is a pharmaceutical company which produces and sells pharmaceutical products.

protech-biosystems-logo

Protech Biosystems

Protech Biosystems is a pharmaceutical company that develops, manufactures, and markets pharma products.

shinpoongco-logo

SHINPOONG.CO

Shinpoong Pharmaceutical Co., Ltd. Date established.

sola-pharmaceuticals-logo

SOLA Pharmaceuticals

Sola Pharmaceuticals is a manufacturer and distributor of pharmaceutical products.

not_available_image

Zhejiang Ausun Pharmaceutical

Zhejiang Ausun Pharmaceutical manufactures and distributes pharmaceutical products.

Stock Details


Company's stock symbol is SSE:603590

Investments List

Date Company Article Money raised
2020-12-07 Nuance Biotech Beijing Konruns Pharmaceutical investment in Series D - Nuance Biotech 181 M USD
2016-10-09 Recomgen Biotech Beijing Konruns Pharmaceutical investment in Series B - Recomgen Biotech 20 M CNY

More informations about "Beijing Konruns Pharmaceutical"

Beijing Konruns Pharmaceutical - Crunchbase

Konruns Pharmaceutical researches, manufactures, and distributes pharmaceutical products. ... 899 Number of Organizations • $301.5B Total Funding Amount • 2,014 Number of Investors. Track . Show More . IPO & …See details»

Beijing Konruns Pharmaceutical Co Ltd - Financial Times

Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. The Company's main product …See details»

603590.SS - | Stock Price & Latest News | Reuters

Nov 14, 2024 Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. ... the world's media …See details»

Beijing Konruns Pharmaceutical Company - PitchBook

Apr 22, 2019 Beijing Konruns Pharmaceutical Company General Information Description. Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, …See details»

Beijing Konruns Pharmaceutical Co.,Ltd. Company Description

Nov 1, 2024 Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The …See details»

Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)

Find the latest Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

Beijing Konruns Pharmaceutical Co.,Ltd. Stock - MarketScreener.com

Jun 30, 2021 Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. The Company's …See details»

603590: Beijing Konruns Pharmaceutical Co.,Ltd. - Summary | Jitta

Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The company offers agkistrodon …See details»

Beijing Konruns PharmaceuticalLtd SHSE:603590 Stock Report

Nov 10, 2024 Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The …See details»

Beijing Konruns Pharmaceutical Co.,Ltd. (SHA: 603590) - Stock …

Oct 10, 2024 Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The …See details»

Beijing Konruns Pharmaceutical Stock Price - Markets Insider

May 16, 2024 Beijing Konruns Pharmaceutical Co., Ltd. engages in the research, development, production and sales of pharmaceuticals. It produces freeze dried powder injection, raw …See details»

November 2024's Leading Growth Companies With Significant …

Overview: Beijing Konruns Pharmaceutical Co., Ltd. is involved in the research, development, production, and sale of pharmaceuticals both in China and internationally, with a market cap of …See details»

Beijing Konruns Pharmaceutical Co Ltd - Financial Times

Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. The Company's main product …See details»

Jincaopian Tablets - Drug Targets, Indications, Patents - Synapse

Nov 21, 2024 Jincaopian Tablets, Initially developed by Beijing Konruns Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 3, Therapeutic Areas: Infectious …See details»

CX1003 in Advanced Solid Tumor - Clinical Trials Registry - ICH GCP

Sep 15, 2019 December 29, 2021 updated by: Beijing Konruns Pharmaceutical Co., Ltd. A Phase 1, Multicenter, Open-label, Dose Escalation/Expansion Study Evaluating the Safety, …See details»

603590 Stock Price Quote - Morningstar

Nov 22, 2024 Beijing Konruns Pharmaceutical Co Ltd Class A. Beijing Konruns Pharmaceutical Co Ltd Class A 603590. Stock XSHG Rating as of Nov 22, 2024. Summary; Chart; News; …See details»

Kanitinib in Solid Tumors - Clinical Trials Registry - ICH GCP

Aug 25, 2016 September 1, 2020 updated by: Beijing Konruns Pharmaceutical Co., Ltd. ... This is where you will find people and organizations involved with this study. Sponsor. Beijing …See details»

Beijing Konruns Pharmaceutical describes new KAT6A inhibitors

Oct 24, 2024 Beijing Konruns Pharmaceutical Co. Ltd. has identified histone acetyltransferase KAT6A (monocytic leukemia zinc finger protein; MOZ; MYST-3) inhibitors reported to be useful …See details»

November 2024's Leading Growth Companies With Significant …

4 days ago Beijing Konruns Pharmaceutical demonstrates potential as a growth company with expected annual earnings growth of 34.3%, surpassing the CN market's 26.2%. Despite this, …See details»

linkstock.net © 2022. All rights reserved